UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Denela-2525-Cream-SE-AJ-MPD-BBDL

Denela 25 mg/g + 25 mg/g Kräm

MPID: SE-100001110-00050703
EURDID: 1867

Full name: Denela 25 mg/g + 25 mg/g Kräm

- Invented Name Part: Denela

- Strength part: 25 mg/g + 25 mg/g

- Pharmaceutical dose form part: Kräm

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Cream

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097205 combinations

Marketing Authorisation 1 of 1

Authorisation number: 50703

Region: Kingdom of Sweden

Marketing authorisation holder: Teva BV

Identifier:

  • LOC-100003164

Status: Valid (2014-06-26)

Package 1 of 2

PCID:

Description:
Tub, 5 x 5 g (med 12 täckförband)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 5 Tube

Package: 1 Box (Cardboard)

Containing:

Package: 5 Tube (Aluminium)

Containing: 5 gram(s)

Manufactured Item

Dose form: Cream

Unit of presentation: Tube

Ingredient

Role: Active

Substance: Lidocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
lidocaine 25 milligram(s) / 1 gram(s)

Ingredient

Role: Active

Substance: Prilocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
Prilocaine 25 milligram(s) / 1 gram(s)

Package 2 of 2

PCID:

Description:
Tub, 30g

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Tube

Package: 1 Box (Cardboard)

Containing:

Package: 1 Tube (Aluminium)

Containing: 30 gram(s)

Manufactured Item

Dose form: Cream

Unit of presentation: Tube

Ingredient

Role: Active

Substance: Lidocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
lidocaine 25 milligram(s) / 1 gram(s)

Ingredient

Role: Active

Substance: Prilocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
Prilocaine 25 milligram(s) / 1 gram(s)

Administrable Product (1 of 1)

Dose form: Cream

Unit of presentation:

Route of administration:

  • Cutaneous use

Ingredients:

Ingredient

Role: Active

Substance: Lidocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
lidocaine 25 milligram(s) / 1 gram(s)

Ingredient

Role: Active

Substance: Prilocaine

Concentration strength: 25 milligram(s) / 1 gram(s)

Reference strength:
Prilocaine 25 milligram(s) / 1 gram(s)